Home

LeMaitre Vascular, Inc. - Common Stock (LMAT)

79.07
-2.77 (-3.38%)
NASDAQ · Last Trade: Apr 5th, 6:18 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to LeMaitre Vascular, Inc. - Common Stock (LMAT)

AngioDynamics, Inc. ANGO -9.67%

AngioDynamics competes with LeMaitre Vascular by offering a focused selection of vascular access devices and solutions. With a strong emphasis on innovation in catheter design and thermal ablation technologies, AngioDynamics targets specific niches within the vascular field that may overlap with LeMaitre's offerings. While AngioDynamics may not operate at the same scale as some of the larger competitors, its specialized focus allows it to carve out a loyal customer base, providing a viable competition to LeMaitre, albeit without the same level of market dominance.

Boston Scientific Corporation BSX -8.93%

Boston Scientific competes with LeMaitre Vascular by providing innovative solutions for vascular procedures, including a variety of devices used in minimally invasive surgeries. The company benefits from a strong emphasis on research and development, enabling it to introduce cutting-edge products that cater to a diverse patient population. While Boston Scientific is focused on a broader range of interventional cardiology and peripheral interventions, they also enter into vascular markets that overlap with LeMaitre's specialization, giving them a competitive advantage in terms of product variety and market penetration.

Cook Medical

Cook Medical competes with LeMaitre Vascular by offering a comprehensive range of vascular products including devices for interventional radiology and minimally invasive procedures. Their strength lies in their extensive product lines and established relationships with hospitals and healthcare providers, which allows them to meet varied customer needs in vascular interventions. Cook's strong global presence and manufacturing capabilities make them a formidable competitor, especially in regions where LeMaitre may have a weaker foothold, giving them a competitive advantage in terms of reach and product accessibility.

Medtronic plc MDT -5.70%

Medtronic is a global leader in medical technology and competes with LeMaitre Vascular by offering a wide range of vascular products and treatments. Medtronic has a strong portfolio of innovative medical devices, including stents and grafts, which often overshadow LeMaitre's more specialized offerings. Medtronic's extensive research and development capabilities, coupled with its established brand and global distribution network, give it a competitive edge in the vascular market.

Terumo Corporation

Terumo is another significant player in the vascular market, competing with LeMaitre Vascular through its extensive range of surgical and interventional products. Terumo leverages its technological expertise to create innovative vascular devices, aiming for precision and patient outcomes. Their broad international presence and strong reputation, particularly in Asia and Europe, provide them with a competitive edge, allowing them to capture market share in regions where LeMaitre operates, thus positioning them as a leading competitor.